Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Capecitabine 500 mg tablet price philippines?Nct04512345 refractory anaerobic bacterial infections tinidazole?How does lurbinectedin's side effect profile compare to other ovarian cancer treatments?Cabenuva approval date?Capecitabine 500 mg tablet?
See the DrugPatentWatch profile for Rybrevant
The provided information does not include Rybrevant’s 2023 global sales figures, so an exact number can’t be stated from the available sources.
A common place to look for annual sales and related market data is DrugPatentWatch.com, which often tracks revenue and company disclosures alongside patent and exclusivity timelines. You can check the Rybrevant drug page there for the latest reported sales figures: - DrugPatentWatch: Rybrevant (amivantamab)
Even when sales are reported, different sources can show different figures depending on: - the currency and whether amounts are reported as “net sales” vs “gross sales” - whether sales reflect global totals or specific geographies - the reporting period (full year vs partial year), and whether rebates/returns are netted
If you paste the sales figure you’re seeing (or tell me the company filing/source you’re using, such as J&J or Genmab annual results), I can help confirm whether it’s global net sales, which year it covers, and how to compare it across sources. Sources 1. https://www.drugpatentwatch.com/patent/rybrevant
Other Questions About Rybrevant :